Naomi Kawashima

Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11

Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta et al. · Blood Advances · 2020 · 127 citations · Full text

Medicine, Hematology, Oncology +15

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning

Junichi Sugita, Naomi Kawashima, Tomoaki Fujisaki et al. · Biology of Blood and Marrow Transplantation · 2015 · 110 citations · Full text

Medicine, Hematology, Immunology +17

Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells

Naomi Kawashima, Yuichi Ishikawa, Jeong Hui Kim et al. · Nature Communications · 2022 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +14

Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study

Naomi Kawashima, Akimi Akashi, Yasunobu Nagata et al. · Annals of Hematology · 2018 · 25 citations · Full text

Medicine, Genetics, Molecular Genetics +14

Mutation analysis of therapy-related myeloid neoplasms

Takahiro Nishiyama, Yuichi Ishikawa, Naomi Kawashima et al. · Cancer Genetics · 2018 · 23 citations · Full text

Medicine, Genetics, Molecular Genetics +14